A topical preparation comprising at least one antibody to human interleukin-8 (IL-8) and a pharmaceutically acceptable carrier for topical treatment of patients with skin inflammatory disease; wherein said antibody is a chimeric antibody; and wherein said chimeric antibody does not comprise an old World monkey variable region which binds to said human IL-8. 27.